Relmada Therapeutics, Inc. (RLMD)
2.615
-0.50
(-15.92%)
USD |
NASDAQ |
Nov 20, 16:00
2.615
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Gross Profit (TTM) : 0.00 for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.0005M |
| December 31, 2021 | -0.0013M |
| September 30, 2021 | -0.0021M |
| June 30, 2021 | -0.0029M |
| March 31, 2021 | -0.0035M |
| December 31, 2020 | -0.0038M |
| September 30, 2020 | -0.004M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0042M |
| March 31, 2020 | -0.0045M |
| June 30, 2019 | -0.0049M |
| March 31, 2019 | -0.0047M |
| December 31, 2018 | -0.0042M |
| September 30, 2018 | -0.0035M |
| June 30, 2018 | -0.0026M |
| March 31, 2018 | -0.02M |
| December 31, 2017 | -0.0427M |
| September 30, 2017 | -0.0657M |
| June 30, 2017 | -0.0853M |
| March 31, 2017 | -0.0884M |
| December 31, 2016 | -0.0927M |
| September 30, 2016 | -0.072M |
| June 30, 2016 | -0.0548M |
| March 31, 2016 | -0.0368M |
| December 31, 2015 | -0.0117M |
| September 30, 2015 | -0.0087M |
| June 30, 2015 | -0.0093M |
| March 31, 2015 | -0.006M |
| December 31, 2014 | -0.0036M |
| September 30, 2014 | -0.0037M |
| February 28, 2014 | 0.0002M |
| September 30, 2013 | 0.0006M |
| August 31, 2013 | 0.0009M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Talphera, Inc. | 0.00 |
| Journey Medical Corp. | 41.70M |
| ANI Pharmaceuticals, Inc. | 553.08M |
| Corcept Therapeutics, Inc. | 949.55M |
| Veru, Inc. | -0.113M |